Specific ab1'-antibodies against tumour-associated antigen ca 125
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 23, 2006
app pub date -
Mar 7, 2003
filing date -
Mar 8, 2002
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention concerns specific anti-anti-idiotypic antibodies which react with anti-idiotypic antibodies which represent an internal image of the antigen CA125 and which also bind to the antigen itself i.e. are specific for the tumour-associated antigen CA125. In particular the present invention concerns a CA125-specific anti-anti-idiotypic antibody which reacts with the anti-idiotypic antibody ACA125. In addition the present invention concerns pharmaceutical compositions containing these anti-anti-idiotypic antibodies for treating tumours that express CA125 and in particular ovarian carcinomas.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully